Immune checkpoint inhibition by anti-PDCD1 (anti-PD1) monoclonal antibody has significant therapeutic activity against central nervous system lymphoma in an immunocompetent preclinical model

Yushi Qiu, Zhimin Li, Frederic Pouzoulet, Prakash Vishnu, John A III Copland, Keith L Knutson, Carole Soussain, Han W Tun

Research output: Contribution to journalArticle

4 Scopus citations
Original languageEnglish (US)
JournalBritish Journal of Haematology
DOIs
StateAccepted/In press - 2017

Keywords

  • Anti-PDCD1 (anti-PD1)
  • CD274 (PD-L1)
  • PDCD1LG2 (PD-L2)
  • Primary central nervous system lymphoma (PCNSL)
  • Survival

ASJC Scopus subject areas

  • Hematology

Cite this